Breast Cancer
Feature
Harnessing new data on immunotherapies
From the Editor
ASCO 2015: from data and learning, to daily practice
News
RAI given to thyroid CA patients does not increase their breast malignancy occurrence, recurrence
A study showed that radioactive iodine therapy did not significantly increase the incidence of breast cancer subsequent to the diagnosis of...
News
Study suggests mammography results in ‘widespread overdiagnosis’
In regions where more women undergo screening mammography, the detection of small cancers increases but mortality doesn’t change significantly,...
News
Urea cream bests antioxidant ointment to prevent chemo-induced hand-foot syndrome
Key clinical point: Urea cream was superior to Mapisal, an antioxidant-containing ointment, in preventing hand-foot syndrome (HFS) among patients...
News
Insurance, location, income drive breast cancer surgery choices
Travel distance to treatment facilities of more than 28 km is associated with a lower likelihood of having breast-conserving surgery for early...
News
ASCO: HR-deficient breast cancers more likely to respond to carboplatin
Key clinical point: HR deficiency is a biomarker for benefit from neoadjuvant chemotherapy in women with TNBC. Major finding: Women with HR-...
Video
VIDEO: Consider cost in anastrozole vs. tamoxifen for DCIS
Dr. Richard Margolese discusses the costs and side effects of anastrozole vs. tamoxifen after postmenopausal ductal carcinoma in situ.
News
Obesity boosts postmenopausal breast cancer risk
Key clinical point: Women who are overweight and obese have a significantly higher risk of postmenopausal invasive breast cancer, particularly...
Conference Coverage
ASCO: Adjuvant denosumab halves fracture risk for breast cancer patients on AIs
Key clinical point: Denosumab reduces the risk of clinical fractures in postmenopausal women taking AIs for early breast cancer. Major finding:...
News
ASCO: Etirinotecan pegol prolongs life for women with brain, liver mets of breast cancer
Key clinical point: Etirinotecan pegol is efficacious in patients with brain or liver metastases of breast cancer. Major finding: Etirinotecan...